Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity

Abstract

BackgroundGalactosylation of immunoglobulin G (IgG) is reduced in rheumatoid arthritis (RA) and assumed to correlate with inflammation and altered humoral immunity. IgG hypogalactosylation also increases with age. To investigate dependencies in more detail, we compared IgG hypogalactosylation between patients with RA, patients with axial spondyloarthritis (axSpA), and healthy control subjects (HC), and we studied it in RA on the background of HLA-DRB1 shared epitope (SE), anticitrullinated protein antibodies (ACPA), and/or rheumatoid factor (RF) status.MethodsPatients with RA (n = 178), patients with axSpA (n = 126), and HC (n = 119) were characterized clinically, and serum IgG galactosylation was determined by capillary electrophoresis. Markers of disease activity, genetic susceptibility, and serologic response included C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), DAS28, SE, HLA-B27, ACPA, and RF. Expression of glycosylation enzymes, including beta 1–4 galactosyltransferase (B4GALT3) activity, were estimated from transcriptome data for B-cell development (GSE19599) and differentiation to plasma cells (GSE12366).ResultsIgG hypogalactosylation was restricted to RA and associated with increasing CRP levels (p < 0.0001). In axSpA, IgG hypogalactosylation was comparable to HC and only marginally increased upon elevated CRP. Restriction to RA was maintained after correction for CRP and age. Treatment with sulfasalazine resulted in significantly reduced IgG hypogalactosylation (p = 0.003) even after adjusting for age, sex, and CRP (p = 0.009). SE-negative/ACPA-negative RA exhibited significantly less IgG hypogalactosylation than all other strata (vs SE-negative/ACPA-positive, p = 0.009; vs SE-positive/ACPA-negative, p = 0.04; vs SE-positive/ACPA-positive, p < 0.02); however, this indicated a trend only after Bonferroni correction for multiple testing. In SE-positive/ACPA-negative RA IgG hypogalactosylation was comparable to ACPA-positive subsets. The relationship between IgG hypogalactosylation and disease activity was significantly different between strata defined by SE (CRP, p = 0.0003, pBonferroni = 0.0036) and RF (CRP, p < 0.0001, pBonferroni < 0.0012), whereas ACPA strata revealed only a nonsignificant trend (p = 0.15). Gene expression data indicated that the key enzyme for galactosylation of immunoglobulins, B4GALT3, is expressed at lower levels in B cells than in plasma cells.ConclusionsIncreased IgG hypogalactosylation in RA but not in axSpA points to humoral immune response as a precondition. Reduced B4GALT3 expression in B cells compared with plasma cells supports relatedness to early B-cell triggering. The differential influence of RA treatment on IgG hypogalactosylation renders it a potential diagnostic target for further studies.Electronic supplementary materialThe online version of this article (10.1186/s13075-018-1540-0) contains supplementary material, which is available to authorized users.

Autoantibodies as Diagnostic Markers and Mediator of Joint Inflammation in Arthritis

“…In RA patients, levels of IgG galactosylation, bisection, and fucosylation are altered [201, 204, 208–212]. In addition, defective galactosylation in the IgG-Fc glycans was observed in RA patients [204, 213, 214] and arthritic MRL-lpr/lpr mice [215]. It was found that agalactosyl IgG has significantly reduced binding to Clq and to Fc γ Rs [216].…”

Relative Quantitation of Subclass-Specific Murine IgG Fc N-Glycoforms by Multiple Reaction Monitoring

“…SSc is an autoimmune disease causing fibrosis of the skin and internal organs. IgG, as a key component of the immune system, is involved in many autoimmune diseases. , Studying the glycosylation in different IgG subclasses may provide insights into the association of IgG glycosylation with SSc.…”

Glycomic-Based Biomarkers for Ovarian Cancer: Advances and Challenges

“…Glycan migration is mediated by an electric field, leading to the separation of positional glycan isomers and quantification can be achieved using labeled maltose [ 69 , 70 ]. The advantage of this technique is that it has high separation power, only requiring a small sample amount and with a quick turnaround time [ 71 ]. Glycan separation can also be performed on UPLC via hydrophilic interaction and fluorescence detection.…”